| |
PsA N =45
|
Ps N =52
|
Control N =98
|
P
|
|---|
|
Age (years)
|
60.5 ± 8.7
|
61.4 ± 9.1
|
60.1 ± 8.4
|
0.95
|
|
Weight (kg)
|
69.4 ± 8.9
|
71.1 ± 14.2
|
67.8 ± 11.2
|
0.19
|
|
Height (m)
|
1.50 ± 0.7
|
1.50 ± 0.6
|
1.55 ± 0.6
|
0.97
|
|
BMI (kg/m2)
|
29.1 ± 3.6
|
26.6 ± 6.2
|
28.1 ± 4.54
|
0.19
|
|
Within ideal weight range *
| | | | |
|
N (%)
|
7 (15.6)
|
9 (17.3)
|
25 (25.5)
|
0.29
|
|
Overweight†
| | | | |
|
N (%)
|
17 (37.8)
|
22 (42.3)
|
40 (40.8)
|
0.9
|
|
Obese‡
| | | | |
|
N (%)
|
21 (46.7)
|
21 (40.4)
|
33 (33.7)
|
0.31
|
|
Ps Duration (years)
|
24.8 ± 16.2
|
21.8 ± 17.8
|
-
|
0.39
|
|
PsA Duration (years)
|
11 ± 10.5
|
-
|
-
|
-
|
|
PASI
|
2.2 ± 3.3
|
3.2 ± 3.4
|
-
|
0.22
|
|
HAQ
|
0.7 ± 0.5§||
|
0.2 ± 0.3
|
0.1 ± 0.2
|
<0.001
|
|
DAS28
|
3.7 ± 1.4
|
-
|
-
|
-
|
|
PsARC
| | | | |
|
N° of swollen joints
|
3.2 ± 2.9
|
-
|
-
|
-
|
|
N° of painful joints
|
3.5 ± 3.4
|
-
|
-
|
-
|
|
Global evaluation of patient (VAS)
|
4 ± 2.8
|
-
|
-
|
-
|
|
Global evaluation of physician (VAS)
|
3.3 ± 2.4
|
-
|
-
|
-
|
|
Years since of menopause
|
12.7 ± 9.9
|
15.4 ± 10.9
|
12.1 ± 8.6
|
0.22
|
- *BMI 18.50 - 24.99 kg/m2; †BMI 25 - 29.99 kg/m2; ‡BMI ≥ 30 kg/m2
- DAS28, disease activity score 28; HAQ, health assessment questionnaire; PASI, psoriasis area severity index; PsA, psoriatic arthritis; Ps, psoriasis; PsARC, psoriatic arthritis response criteria; VAS, visual analogue scale.
- §P < 0.001 (PsA vs. Ps)
- ||P < 0.001 (PsA vs. control)
